Aurora Biopharma tackling glioblastoma with CAR-T immunotherapy; plans to raise $20M
Immunotherapy is emerging as a powerful tool to treat glioblastoma - an aggressive form of brain cancer. Cambridge startup is developing a CAR-T approach to the disease, and is raising a $20 million Series A to do so.